BOLT - Balance Sheet - Bolt Biotherapeutics, Inc.

Current Liabilities	15.9 M
Accounts Payable	1.51 M
Short-Term Debt	2.25 M
Other Current Liabilities	12.1 M
Non-Current Liabilities	26.6 M
Long-Term Debt	0
Other Non-Current Liabilities	26.6 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	7.2	10.8	9.2	27.4	5.5	34.8	13.6
Short Term Investments	40.1	91.4	159.6	158.8	17.3	0	0
Receivables	1.2	0	0	0	0	0	0
Inventory	1	0	(0.8)	(0.2)	12 K	(0.3)	0
Other Current Assets	2.3	3.5	3.9	2.9	2.5	1.1	0.5
Total Current Assets	50.8	105.7	172.7	189.2	25.4	35.9	14.1
PP&E	24.9	24.1	28.5	30.6	16.4	11.5	1.4
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	22.9	26.4	23.9	85.3	1.6	0.6	0
Other Long Term Assets	1.0	3.6	2.6	2.6	3.2	0.4	0.4
Other Assets	0	0	0	0	0	0	0
Total Assets	99.6	159.8	227.8	307.7	46.5	48.4	16.0
LIABILITIES
Accounts Payable	1.5	3.0	3.6	3.6	1.6	2.1	0.9
Short Term Debt	2.3	2.8	4.8	5.0	3.0	3.1	40 K
Other Current Liabilities	9.1	12.5	12.7	9.9	5.2	2.9	1.8
Total Current Liabilities	15.9	20.5	23.1	21.3	11.3	8.7	2.8
Long Term Debt	0	17.4	20.2	21.9	9.4	(70.4)	0
Deferred Tax Income	0	0	0	0	0	77.5	0
Other Liabilities	0	43 K	42 K	0.2	130.8	(77.4)	29.2
Total Liabilities	42.4	47.0	56.3	57.6	151.5	94.3	31.9
EQUITY
Common Stock	0	1 K	0	0	0	0	0
Retained Earnings	(427.4)	(364.3)	(295.1)	(207.0)	(108.4)	(47.7)	(17.2)
Other Accumulative Comprehensive Income/Loss	0	37 K	(0.9)	(0.3)	0	0	0
Total Equity	57.2	112.7	171.5	250.1	(104.9)	(45.8)	(15.9)
Total Liabilities and Equity	99.6	159.8	227.8	307.7	46.5	48.4	16.0
SHARES OUTSTANDING
Common Shares Outstanding	38.2	37.8	37.4	37.4	36.2	35.1	9.4

Free